ASSEMBLY BIOSCIENCES, INC. (ASMB)
About ASSEMBLY BIOSCIENCES, INC.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $72.3M
- Net income
- -$6.1M
- Total assets
- $257.6M
- Market cap
- $506.3M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $506.3M
- Shares outstanding
- 25.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 17, 2010
Assembly Biosciences, Inc. (ASMB) Stock Price
- Reported a net loss of $6.1M in FY2025.
- Trading 48% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ASSEMBLY BIOSCIENCES, INC..
Write a review
News about ASSEMBLY BIOSCIENCES, INC.
News & sentiment via Polygon.io
Assembly Biosciences, Inc.: frequently asked questions
Is Assembly Biosciences, Inc. an American company?
Assembly Biosciences, Inc. is a US-based company headquartered in South San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Assembly Biosciences, Inc. headquartered?
Assembly Biosciences, Inc. is headquartered in South San Francisco, California, United States.
Is Assembly Biosciences, Inc. publicly traded?
Yes — Assembly Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol ASMB on the NASDAQ.
What does Assembly Biosciences, Inc. do?
Assembly Biosciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
